Doxorubicin-induced congestive heart failure in elderly patients with metastatic breast cancer, with long-term follow-up : the M.D. Anderson experience

• Published in: Cancer chemotherapy and pharmacology Vol. 43; no. 6; pp. 471 - 478
• Main Authors: IBRAHIM, N. K, HORTOBAGYI, G. N, EWER, M, ALI, M. K, ASMAR, L, THERIAULT, R. L, FRASCHINI, G, FRYE, D. K, BUZDAR, A. U
• Format: Journal Article
• Language: English
• Published: Berlin Springer 1999
• Subjects: Aged; Aged, 80 and over; Antibiotics, Antineoplastic - adverse effects; Antineoplastic agents; Biological and medical sciences; Breast Neoplasms - drug therapy; Chemotherapy; Doxorubicin - adverse effects; Female; Follow-Up Studies; Heart Failure - chemically induced; Humans; Medical sciences; Middle Aged; Neoplasm Metastasis; Pharmacology. Drug treatments; Retrospective Studies; Human; Antineoplastic agent; Heart failure; Intravenous administration; Cardiovascular disease; Malignant tumor; Doxorubicin; Long term; Mammary gland diseases; Chemotherapy; Treatment; Heart disease; Risk factor; Secondary effect; Advanced stage; Anthracyclins; Mammary gland; Retrospective searching; Elderly

Correlation between aging and doxorubicin-induced congestive heart failure in patients with metastatic breast cancer was studied to determine whether doxorubicin-induced congestive heart failure in elderly patients with metastatic breast cancer is a clinically significant issue. This was a retrospec...